Get 20% lifetime commission for referring investors to digrin.com
here.
MiMedx Group, Inc. ( MDXG) - Key Metrics
MDXG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.44 | -$0.10 | -$0.07 | -$0.07 |
| 2026Q1 | $0.40 | -$0.07 | $0.01 | $0.01 |
| 2025Q4 | $0.80 | $0.10 | $0.17 | $0.17 |
| 2025Q3 | $0.77 | $0.11 | $0.20 | $0.17 |
| 2025Q2 | $0.67 | $0.07 | $0.10 | $0.10 |
MDXG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.63 |
| 2026Q1 | 0% | -14.11 |
| 2025Q4 | 0% | 16.92 |
| 2025Q3 | 0% | 15.86 |
| 2025Q2 | 0% | 23.46 |
MDXG
Price: $4.19
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.04 USD
P/E Ratio: 106.75
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 527584
Ebitda: 10.3 millionMarket Capitalization: 621.7 million